4D Molecular Therapeutics Inc — Form D
4D Molecular Therapeutics Inc of EMERYVILLE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-08-13. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-08-13
- Form: D
- Accession: 0001650648-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $7.0M
- Investors: 1
- Date of first sale: 2015-08-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-245752
Issuer
- Name: 4D Molecular Therapeutics Inc
- CIK: 0001650648
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 5980 HORTON STREET, EMERYVILLE, CA, 94608
- Phone: (510) 505-2680
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Margi McLoughlin | Director | South San Francisco, CA |
| Sharon Tetlow | Director | San Francisco, CA |
| Tony Yao | Director | Denver, CO |
| Theresa Janke | Executive Officer | Emeryville, CA |
| Margi McLaughlin | Director | Emeryville, CA |
| David Kirn, M.D. | Director | Emeryville, CA |
| David Kirn, M.D. | Executive Officer | Emeryville, CA |
| Peter Francis, M.D. | Executive Officer | Emeryville, CA |
| Hoyoung Huh, M.D., Ph.D. | Director | Emeryville, CA |
| Leisa Johnson, Ph.D. | Executive Officer | Emeryville, CA |
| Charles Theuer, Ph.D. | Director | Emeryville, CA |
| David Schaffer, Ph.D., | Director | Emeryville, CA |
| David Schaffer, Ph.D., | Executive Officer | Emeryville, CA |
| David Kirn | Director | Emeryville, CA |
| David Kirn | Executive Officer | Emeryville, CA |
| David Schaffer | Director | Emeryville, CA |
Other filings by this issuer (2)
More